BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 22495704)

  • 1. Radiotherapy in Italy for non-small cell lung cancer: patterns of care survey.
    Ramella S; Maranzano E; Frata P; Mantovani C; Lazzari G; Menichelli C; Navarria P; Pergolizzi S; Salvi F
    Tumori; 2012; 98(1):66-78. PubMed ID: 22495704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patterns of practice in the radiation therapy management of rectal cancer: survey of the Interregional Group Piedmont, Valle d'Aosta and Liguria of the "Associazione Italiana di Radioterapia Oncologica (AIRO)".
    Di Genesio Pagliuca M; Turri L; Munoz F; Melano A; Bacigalupo A; Franzone P; Sciacero P; Tseroni V; Vitali ML; Delmastro E; Scolaro T; Marziano C; Orsatti M; Tessa M; Rossi A; Ballare A; Moro G; Grasso R; Krengli M
    Tumori; 2013; 99(1):61-7. PubMed ID: 23549002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Practice patterns for oropharyngeal cancer in radiation oncology centers of Turkey.
    Karakoyun-Celik O; Altun M; Olmezoglu A; Büyükpolat MY; Ozkök S; Akmansu M; Cengiz M; Onal C; Dizman A; Esassolak M
    Tumori; 2014; 100(3):284-8. PubMed ID: 25076239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patterns of care survey (PCS) in lung cancer: how well does current U.S. practice with chemotherapy in the non-metastatic setting follow the literature?
    Langer CJ; Moughan J; Movsas B; Komaki R; Ettinger D; Owen J; Wilson JF
    Lung Cancer; 2005 Apr; 48(1):93-102. PubMed ID: 15777975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac Dose in Locally Advanced Lung Cancer: Results From a Statewide Consortium.
    Dess RT; Sun Y; Muenz DG; Paximadis PA; Dominello MM; Grills IS; Kestin LL; Movsas B; Masi KJ; Matuszak MM; Radawski JD; Moran JM; Pierce LJ; Hayman JA; Schipper MJ; Jolly S;
    Pract Radiat Oncol; 2020; 10(1):e27-e36. PubMed ID: 31382026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The acute and late toxicity results of a randomized phase II dose-escalation trial in non-small cell lung cancer (PET-boost trial).
    van Diessen J; De Ruysscher D; Sonke JJ; Damen E; Sikorska K; Reymen B; van Elmpt W; Westman G; Fredberg Persson G; Dieleman E; Bjorkestrand H; Faivre-Finn C; Belderbos J
    Radiother Oncol; 2019 Feb; 131():166-173. PubMed ID: 30327236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The predictive value of
    Mattoli MV; Massaccesi M; Castelluccia A; Scolozzi V; Mantini G; Calcagni ML
    Radiat Oncol; 2017 Jan; 12(1):4. PubMed ID: 28057034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study.
    Bradley JD; Paulus R; Komaki R; Masters G; Blumenschein G; Schild S; Bogart J; Hu C; Forster K; Magliocco A; Kavadi V; Garces YI; Narayan S; Iyengar P; Robinson C; Wynn RB; Koprowski C; Meng J; Beitler J; Gaur R; Curran W; Choy H
    Lancet Oncol; 2015 Feb; 16(2):187-99. PubMed ID: 25601342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FDG-PET in staging and restaging non-small cell lung cancer after neoadjuvant chemoradiotherapy: correlation with histopathology.
    Ryu JS; Choi NC; Fischman AJ; Lynch TJ; Mathisen DJ
    Lung Cancer; 2002 Feb; 35(2):179-87. PubMed ID: 11804691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of endometrial cancer in Italy: a national survey endorsed by the Italian Society of Gynecologic Oncology.
    Greggi S; Franchi M; Aletti G; Biglia N; Ditto A; Fagotti A; Giorda G; Mangili G; Odicino F; Salerno MG; Vizza E; Scaffa C; Scollo P
    Int J Surg; 2014 Oct; 12(10):1038-44. PubMed ID: 25150805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Penetration of recommended procedures for lung cancer staging and management in the United States over 10 years: a quality research in radiation oncology survey.
    Komaki R; Khalid N; Langer CJ; Kong FM; Owen JB; Crozier CL; Wilson JF; Wei X; Movsas B
    Int J Radiat Oncol Biol Phys; 2013 Mar; 85(4):1082-9. PubMed ID: 23273996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Present clinical practice of breast cancer radiotherapy in Italy: a nationwide survey by the Italian Society of Radiotherapy and Clinical Oncology (AIRO) Breast Group.
    Gregucci F; Fozza A; Falivene S; Smaniotto D; Morra A; Daidone A; Barbara R; Ciabattoni A;
    Radiol Med; 2020 Jul; 125(7):674-682. PubMed ID: 32078120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The management of lung cancer: a UK survey of oncologists.
    Prewett SL; Aslam S; Williams MV; Gilligan D
    Clin Oncol (R Coll Radiol); 2012 Aug; 24(6):402-9. PubMed ID: 22516859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of [18F]fluorodeoxyglucose PET-CT staging on treatment planning in radiotherapy incorporating elective nodal irradiation for non-small-cell lung cancer: a prospective study.
    Kolodziejczyk M; Kepka L; Dziuk M; Zawadzka A; Szalus N; Gizewska A; Bujko K
    Int J Radiat Oncol Biol Phys; 2011 Jul; 80(4):1008-14. PubMed ID: 20656419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neo-adjuvant chemotherapy followed by either continuous hyper-fractionated accelerated radiation therapy week-end less or conventional chemo-radiotherapy in locally advanced NSCLC-A randomised prospective single institute study.
    Kumar R; Kumar HS; Paramanandhan M; Purohit R; Sharma N; Jakhar SL; Sharma S; Maharia S; Rai RK
    J Cancer Res Ther; 2020; 16(4):860-866. PubMed ID: 32930131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. F-18-FDG-PET confined radiotherapy of locally advanced NSCLC with concomitant chemotherapy: results of the PET-PLAN pilot trial.
    Fleckenstein J; Hellwig D; Kremp S; Grgic A; Gröschel A; Kirsch CM; Nestle U; Rübe C
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e283-9. PubMed ID: 21470782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imaging-based target volume reduction in chemoradiotherapy for locally advanced non-small-cell lung cancer (PET-Plan): a multicentre, open-label, randomised, controlled trial.
    Nestle U; Schimek-Jasch T; Kremp S; Schaefer-Schuler A; Mix M; Küsters A; Tosch M; Hehr T; Eschmann SM; Bultel YP; Hass P; Fleckenstein J; Thieme A; Stockinger M; Dieckmann K; Miederer M; Holl G; Rischke HC; Gkika E; Adebahr S; König J; Grosu AL;
    Lancet Oncol; 2020 Apr; 21(4):581-592. PubMed ID: 32171429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of T3 laryngeal cancer in the Netherlands: a national survey.
    Doornaert P; Terhaard CH; Kaanders JH;
    Radiat Oncol; 2015 Jun; 10():134. PubMed ID: 26112272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FDG-PET parameters as predictors of pathologic response and nodal clearance in patients with stage III non-small cell lung cancer receiving neoadjuvant chemoradiation and surgery.
    Arnett AL; Packard AT; Mara K; Mansfield AS; Wigle DA; Haddock MG; Park SS; Olivier KR; Garces YI; Merrell KW
    Pract Radiat Oncol; 2017; 7(6):e531-e541. PubMed ID: 28733185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiotherapy in Italy after conservative treatment of early breast cancer. A survey by the Italian Society of Radiation Oncology (AIRO).
    Aristei C; Amichetti M; Ciocca M; Nardone L; Bertoni F; Vidali C;
    Tumori; 2008; 94(3):333-41. PubMed ID: 18705400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.